$1.2926
7.75%
Downside
Day's Volatility :14.39%
Upside
7.19%
2.33%
Downside
52 Weeks Volatility :84.73%
Upside
84.36%
Period | Lamf Global Ventures I Corp | Index (Russel 2000) |
---|---|---|
3 Months | -71.76% | 0.0% |
6 Months | -71.76% | 0.0% |
1 Year | -71.76% | 0.0% |
3 Years | -71.76% | -22.6% |
Market Capitalization | 43.6M |
Book Value | - $1.89 |
Earnings Per Share (EPS) | -2.23 |
Profit Margin | 0.0% |
Operating Margin TTM | -17524.49% |
Return On Assets TTM | 0.0% |
Return On Equity TTM | 0.0% |
Revenue TTM | 0.0 |
Revenue Per Share TTM | 0.0 |
Quarterly Revenue Growth YOY | 0.0% |
Gross Profit TTM | 0.0 |
EBITDA | -24.0M |
Diluted Eps TTM | -2.234 |
Quarterly Earnings Growth YOY | 0.0 |
EPS Estimate Current Year | 0.0 |
EPS Estimate Next Year | 0.0 |
EPS Estimate Current Quarter | 0.0 |
EPS Estimate Next Quarter | 0.0 |
Sell
Neutral
Buy
Lamf Global Ventures I Corp is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
Lamf Global Ventures I Corp | -74.67% | -71.76% | -71.76% | -71.76% | -71.76% |
Stryker Corporation | 4.27% | 16.65% | 22.1% | 34.77% | 82.03% |
Boston Scientific Corp. | 4.07% | 37.57% | 46.89% | 79.16% | 88.7% |
Edwards Lifesciences Corp. | 3.26% | 26.96% | 1.71% | -9.27% | 51.45% |
Abbott Laboratories | -2.62% | -2.21% | -0.86% | -5.87% | 32.8% |
Medtronic Plc | 0.44% | 2.96% | -1.92% | -33.69% | -13.02% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
Lamf Global Ventures I Corp | NA | NA | NA | 0.0 | 0.0 | 0.0 | NA | -1.89 |
Stryker Corporation | 38.89 | 38.89 | 2.92 | 11.96 | 0.19 | 0.07 | 0.01 | 50.33 |
Boston Scientific Corp. | 63.5 | 63.5 | 1.8 | 2.33 | 0.09 | 0.05 | NA | 13.56 |
Edwards Lifesciences Corp. | 37.45 | 37.45 | 5.19 | 2.76 | 0.21 | 0.12 | NA | 11.82 |
Abbott Laboratories | 31.83 | 31.83 | 5.99 | 4.63 | 0.15 | 0.06 | 0.02 | 22.31 |
Medtronic Plc | 29.48 | 29.48 | 1.52 | 5.2 | 0.07 | 0.04 | 0.03 | 38.29 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
Lamf Global Ventures I Corp | NA | $43.6M | -71.76% | NA | 0.0% |
Stryker Corporation | Buy | $129.9B | 82.03% | 38.89 | 16.03% |
Boston Scientific Corp. | Buy | $111.1B | 88.7% | 63.5 | 12.05% |
Edwards Lifesciences Corp. | Buy | $52.4B | 51.45% | 37.45 | 23.01% |
Abbott Laboratories | Buy | $177.8B | 32.8% | 31.83 | 13.96% |
Medtronic Plc | Buy | $106.7B | -13.02% | 29.48 | 11.36% |
Organization | Lamf Global Ventures I Corp |
Employees | 0 |
CEO | |
Industry | Miscellaneous |
A Spac I Acquisition Corp
$1.29
-2.81%
Keyarch Acquisition Corp
$1.29
-2.81%
Connexa Sports Technologies Inc
$1.29
-2.81%
Us Value Etf
$1.29
-2.81%
First Wave Biopharma Inc
$1.29
-2.81%
Global X Msci Next Emerging
$1.29
-2.81%
Fat Projects Acquisition Corp
$1.29
-2.81%
Capital Link Global Fintech
$1.29
-2.81%
Applied Uv Inc
$1.29
-2.81%